Award
NIH Reporter #5R01DA059234-04
Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial
Recipient
Not specified
Award Amount
$694,985.00
Ceiling
$694,985.00
Awarded
July 22, 2026
Identifier
5R01DA059234-04
Award for a research project studying hemp-derived cannabidiol as a treatment for cannabis use disorder through a double-blind placebo-controlled randomized trial.
Description
NIH grant opportunity for research on hemp-derived CBD for cannabis use disorder involving a randomized controlled trial with a focus on public health impact.